Clinical Trials
13 trialsNCT06940271 2025-11-10
RAP
Mayo Clinic
Phase NA Recruiting
NCT06571825 2024-08-26
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
Zhejiang University
Phase 4 Recruiting
NCT01814488 2023-03-10
Gandalf-01
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2 Completed
NCT00096460 2023-01-05
BMT CTN 0202
Medical College of Wisconsin
Phase 2/3 Terminated
NCT01364363 2022-11-23
Unrelated Donor Stem Cell Transplantation
Scripps Health
Phase NA Completed
NCT00841152 2021-03-16
BAGvsTCP
Turku University Hospital
Completed
NCT00506129 2020-12-29
Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00612716 2020-12-09
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT01490723 2020-05-05
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01588951 2018-08-14
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2/3 Terminated
NCT00354172 2017-12-28
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00974623 2017-04-05
APPROACH-001
Baxter Healthcare Corporation
Terminated
NCT00146055 2012-08-09
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
University of Michigan Rogel Cancer Center
Phase 2 Completed